Search research articles
Contact Us
Filters
Showing results (111-120 of 380) with videos related to
Page
of 38
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 17, 2017
Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
Narendranath Epperla, Kwang Woo Ahn, Philippe Armand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2008
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou, Carmen Canals, Anthony Goldstone, et al.
Haematologica
|
July 21, 2007
The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma
José Rodríguez, Eulogio Conde, Antonio Gutiérrez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou, Carmen Canals, Jan J Cornelissen, et al.
Leukemia & Lymphoma
|
January 18, 2013
Pharmacogenetic analysis in the treatment of Hodgkin lymphoma
Albert Altés, Laia Paré, Albert Esquirol, et al.
Leukemia & Lymphoma
|
December 1, 2018
Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes
Julia Montoro, Helena Pomares, Guillermo Villacampa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou, Carmen Canals, David Sibon, et al.
Haematologica
|
October 8, 2008
Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry
Esa Jantunen, Carmen Canals, Alessandro Rambaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study
Anas Younes, Anna Sureda, Dina Ben-Yehuda, et al.
Oncology and Therapy
|
July 24, 2020
Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis
Rocío Parody, Isabel Sánchez-Ortega, Christelle Ferrá, et al.
Page
of 38
Search research articles
Search
Showing results (111-120 of 380) with videos related to
Sort By:
Page
of 38
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 17, 2017
Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
Narendranath Epperla, Kwang Woo Ahn, Philippe Armand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2008
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou, Carmen Canals, Anthony Goldstone, et al.
Haematologica
|
July 21, 2007
The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma
José Rodríguez, Eulogio Conde, Antonio Gutiérrez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou, Carmen Canals, Jan J Cornelissen, et al.
Leukemia & Lymphoma
|
January 18, 2013
Pharmacogenetic analysis in the treatment of Hodgkin lymphoma
Albert Altés, Laia Paré, Albert Esquirol, et al.
Leukemia & Lymphoma
|
December 1, 2018
Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes
Julia Montoro, Helena Pomares, Guillermo Villacampa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou, Carmen Canals, David Sibon, et al.
Haematologica
|
October 8, 2008
Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry
Esa Jantunen, Carmen Canals, Alessandro Rambaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study
Anas Younes, Anna Sureda, Dina Ben-Yehuda, et al.
Oncology and Therapy
|
July 24, 2020
Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis
Rocío Parody, Isabel Sánchez-Ortega, Christelle Ferrá, et al.
Page
of 38